Skip to main content

Gene Data, Novartis

Premium

Gene Data of Basel, Switzerland, last week released two new modules for its analysis suite of products.

The firm, a 1997 spinout from Novartis, introduced Screener Condenser and Screener Analyst for its GeneData Screener system for the analysis of high-throughput screening data.

The Condenser product performs data standardization as well as data annotation. It is designed to integrate results from primary and secondary screening into bioactivity profiles.

The Analyst product is used for cross-assay compound profiling based on HTS data. It is intended for large-scale assay comparisions, biological activity profiling of compounds or compound libraries across large numbers of assays, separation of mechanisms of actions, and identification of chemical structural elements conferring a desired biological activity. The products, together, are intended to provide a data analysis workflow. They were developed in collaboration with the pharmaceutical company Altana Pharma.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.